Company Directory - Research & Development
By integrating our proprietary COMPASS platform with our extensive technological and drug discovery capabilities, our team of scientific pioneers are working to accelerate the development of new precision medicines that change the course of disease.
MedAustron, the center for ion therapy and research is located in Wiener Neustadt in Lower Austria, about 50 kilometers south of Vienna. 180 employees coming from about 18 different countries are currently working for MedAustron. These include physicians, physicists, engineers, medical physicists, radiology technologists and administrative staff.
MedAustron in Wiener Neustadt, Austria, is one of the world’s most cutting-edge centers for cancer treatment and research. It started treating patients in Dezember 2016. MedAustron uses an innovative form of radiation therapy, namely ion beam therapy. Patients get irradiated with charged particles – protons or carbon ions.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm supports clients in mitigating development risks, creating data packages more likely to attract investors and support submissions that inspire regulators’ confidence.
MMV is a leading product development partnership (PDP) in antimalarial drug research. Its mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and delivering new, effective and affordable antimalarial drugs.
Medigene is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. With its scientific expertise, Medigene is working on the development of innovative immunotherapies to treat cancer such as T cell receptor-modified T cells (TCR‑Ts) or dendritic cell (DC) vaccines in fields of high medical need.
Medlab Clinical Ltd is an Australian, publicly listed biotechnology company that formulates and enhances viable therapeutic solutions. Our team of scientists, researchers and doctors are dedicated to building products that are scientifically optimised for a better life.
In its 10 Research & Development centers, Menarini’s main focus is dedicated to therapeutic areas with unresolved pathologies, such as oncology and anti-infectives (AMR), where increasing treatment options is fundamental to helping those in need.
For 130 years, Merck (known as MSD outside of the U.S. and Canada) has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.
We are here for people at every step, helping to create, im-prove and prolong life. We deliver personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. We empower the scientific community.
The Metrion team has substantial experience of providing high quality drug discovery services for ion channel targets to clients on a fee-for-service or collaboration basis. Metrion is also a leading provider of cardiac safety profiling, cardiac translational assays and neuronal translational assays.
Mobidiag is a revenue generating, fast growing molecular diagnostics company with complementary platform technologies...
Moderna is advancing messenger RNA (mRNA) science to create a new class of transformative medicines for patients.
As our name indicates, collaboration is in our DNA: within our team, with our partners, and with patients and providers. We build on deep trust, individual diversity, and shared passion to reach our common goal of surmounting the toughest challenges in medicine, including the treatment of cancer and other serious diseases.
Our mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Innovative technologies and smart development strategies are central to our approach.
Murdoch Children's Research Institute (MCRI) is the largest child health research institute in Australia and one of the top three worldwide for research quality and impact*. Our team of more than 1200 talented researchers is dedicated to making discoveries to prevent and treat childhood conditions.
We aspire to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Our experienced team brings significant breadth and depth of expertise in drug development, combined with a commitment to develop new treatments for women suffering from uterine fibroids, endometriosis, and infertility, and men suffering from prostate cancer.
